BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND FANCG, ENSG00000221829, 2189, O15287, XRCC9, FAG AND Diagnosis
6 results:

  • 1. [Treatment responses, outcomes, and prognostic factors associated with them in patients with secondary acute myeloid leukemia].
    Ma L; Zhao T; Chen YY; Jiang H; Xu LP; Zhang XH; Wang Y; Sun YQ; Mo XD; Huang XJ; Jiang Q
    Zhonghua Xue Ye Xue Za Zhi; 2023 Feb; 44(2):124-131. PubMed ID: 36948866
    [No Abstract]    [Full Text] [Related]  

  • 2. Genetic analysis of a Fanconi anemia case revealed the presence of FANCF mutation (exon 1;469>C-T) with implications to develop acute myeloid leukemia.
    Behera CK; Gyandeep G; Mishra R; Mohanty RP; Pal A; Behera J; Samal S; Das B
    Mol Biol Rep; 2023 Jan; 50(1):931-936. PubMed ID: 36369330
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Time-Dependent Risk of Cancer After a Diabetes diagnosis in a Cohort of 2.3 Million Adults.
    Dankner R; Boffetta P; Balicer RD; Boker LK; Sadeh M; Berlin A; Olmer L; Goldfracht M; Freedman LS
    Am J Epidemiol; 2016 Jun; 183(12):1098-106. PubMed ID: 27257115
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Fanconi anemia.
    Soulier J
    Hematology Am Soc Hematol Educ Program; 2011; 2011():492-7. PubMed ID: 22160080
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Identification and characterization of mutations in FANCL gene: a second case of Fanconi anemia belonging to FA-L complementation group.
    Ali AM; Kirby M; Jansen M; Lach FP; Schulte J; Singh TR; Batish SD; Auerbach AD; Williams DA; Meetei AR
    Hum Mutat; 2009 Jul; 30(7):E761-70. PubMed ID: 19405097
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The molecular biology of Fanconi anemia.
    Tamary H; Bar-Yam R; Zemach M; Dgany O; Shalmon L; Yaniv I
    Isr Med Assoc J; 2002 Oct; 4(10):819-23. PubMed ID: 12389351
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.